4.8 Article

ChIP-Seq of transcription factors predicts absolute and differential gene expression in embryonic stem cells

出版社

NATL ACAD SCIENCES
DOI: 10.1073/pnas.0904863106

关键词

ChIP binding; pluripotency; RNA-Seq; transcription regulation

资金

  1. National Institutes of Health [R01HG004634, R01HG003903]
  2. National Science Foundation [DMS-0805491]
  3. California Institute for Regenerative Medicine (CIRM) [RC1-00133]
  4. Division Of Mathematical Sciences
  5. Direct For Mathematical & Physical Scien [0805491] Funding Source: National Science Foundation

向作者/读者索取更多资源

Next-generation sequencing has greatly increased the scope and the resolution of transcriptional regulation study. RNA sequencing (RNA-Seq) and ChIP-Seq experiments are now generating comprehensive data on transcript abundance and on regulator-DNA interactions. We propose an approach for an integrated analysis of these data based on feature extraction of ChIP-Seq signals, principal component analysis, and regression-based component selection. Compared with traditional methods, our approach not only offers higher power in predicting gene expression from ChIP-Seq data but also provides a way to capture cooperation among regulators. In mouse embryonic stem cells (ESCs), we find that a remarkably high proportion of variation in gene expression (65%) can be explained by the binding signals of 12 transcription factors (TFs). Two groups of TFs are identified. Whereas the first group (E2f1, Myc, Mycn, and Zfx) act as activators in general, the second group (Oct4, Nanog, Sox2, Smad1, Stat3, Tcfcp2l1, and Esrrb) may serve as either activator or repressor depending on the target. The two groups of TFs cooperate tightly to activate genes that are differentially up-regulated in ESCs. In the absence of binding by the first group, the binding of the second group is associated with genes that are repressed in ESCs and derepressed upon early differentiation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据